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Atranorin (ATR) is the main compound from the lichen Cladina kalbii Ahti, which grows in the arid regions 
of northeastern Brazil. This study was conducted to evaluate the anti-inflammatory and toxicological 
properties of ATR. To evaluate anti-inflammatory properties, paw edema was induced by injecting 0.1 
mL of carrageenan into the subplantar region of the right hind paw of rats, and leukocyte migration was 
induced by injection of 500 µL of carrageenan into the peritoneal cavity of mice. In addition, we determined 
ATR cytotoxicity in L929 cells by MTT assay and acute (5 g/kg-single dose) and subchronic (50 mg/kg-
30 days) toxicity tests in Wistar rats. The results showed that ATR (100 mg/kg and 200 mg/kg) exhibited 
significant anti-inflammatory activity (paw edema and leukocyte migration). In the acute toxicity test, 
the animals showed hypoactivity and lethargy during the initial period (first 6 hours) and increase in total 
protein, total and indirect bilirubin, and alkaline phosphatase after 14 days in ATR-treated male rats. The 
subchronic toxicity test revealed increases in total protein, globulin, gamma-glutamyl transferase, alkaline 
phosphatase, and total and direct bilirubin in ATR-treated female rats. Histological analysis revealed no 
changes in the architecture and morphology of the organs. These results suggest that ATR has significant 
anti-inflammatory activity, with no significant acute and subchronic toxicity or cytotoxicity.
Uniterms: Cladina kalbii/pharmacognosy. Atranorin/anti-inflamatory activity. Atranorin/toxicity. 
Medicinal plants. 
Atranorina (ATR) é o principal composto do líquen Cladina kalbii Ahti, que cresce em terras áridas do 
nordeste brasileiro. Este estudo foi realizado para avaliar as propriedades antiinflamatórias e toxicológicas 
da ATR. Para avaliar as propriedades antiinflamatórias, o edema de pata foi induzido, administrando-se 
0,1 mL de carragenina na região subplantar da pata traseira direita e a migração leucocitária foi induzida 
pela injeção de 500 µL de carragenina no peritônio. Além disso, determinou-se a citotoxicidade da ATR, 
utilizando-se a linhagem celular L929, através do teste de MTT e dos testes de toxicidade aguda (5 g/kg 
- dose única) e subcrônica (50 mg/kg-30 dias) em ratos Wistar. Os resultados mostraram que nas doses 
de (100 mg/kg e 200 mg/kg) a ATR exibiu atividade antiinflamatória significativa nos ensaios de edema 
de pata e migração leucocitária. Nos testes de toxicidade aguda, os animais apresentaram hipoatividade e 
letargia no período inicial (primeiras 6 horas) e aumento das proteínas totais, bilirrubinas total e indireta 
e fosfatase alcalina depois de 14 dias nos machos tratados. Para o ensaio subcrônico, houve aumento 
das proteínas totais, gama-glutamil-transferase, fosfatase alcalina e bilirrubina total e direta nas fêmeas 
tratadas com ATR. Não foram encontradas alterações na arquitetura e morfologia das lâminas histológicas 
observadas. Esses resultados sugerem que a ATR apresenta atividade antiinflamatória significativa, sem 
apresentar significativa toxicidade aguda, subcrônica e citotoxicidade.
Unitermos: Cladina kalbii/farmacognosia. Atranorina/atividade antiinflamatória. Atranorina/toxicidade. 
Plantas medicinais. 
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INTRODUCTION
Lichens are some of the most important sources of 
biologically active compounds (Barnes et al., 2000). They 
have a worldwide distribution and live in a symbiotic 
relationship with fungi (mycobiont), algae (phycobiont), 
and/or cyanobacteria (photobiont) (Honegger, 1991). 
This symbiosis provides physical protection, water, and 
mineral supply for both partners. They produce common 
intracellular constituents, including proteins, amino acids, 
polyols, carotenoids, polysaccharides, and vitamins. The 
secondary metabolites found in lichens are phenolics that 
accumulate either in the cortex or in the cell walls of med-
ullary hyphae, and they are mainly acetyl-polymalonyl 
pathway derivatives (Honda, Vilegas, 1999). Furthermore, 
lichens are able to synthesize several metabolites, which 
are composed of aliphatic, cycloaliphatic, aromatic, and 
terpenic compounds (Huneck, 1999).
Polysaccharides, proteins, and secondary metabo-
lites produced by lichens have attracted the attention of 
investigators due to their biological activities. For centu-
ries, a number of the 17,000 known lichen species have 
been used by humans for medicinal purposes. In the 
northeastern region of Brazil, lichen species vary accord-
ing to the environment, from the coastal zone (humid) to 
the inner region, where the climate is semi-arid (caatinga). 
In these habitats, several species are considered to be 
bioactive (Maia et al., 2002; Pereira, 1996). Atranorin 
(ATR) (Figure 1) is the main compound from the lichen 
Cladina kalbii Ahti, which grows in the arid regions of 
northeastern Brazil. ATR is an important member of the 
depside group. The molecular structures of these depsides 
present aromatic esters with a methyl ester terminal group 
(Howell et al., 2003). 
Studies on the pharmacological properties of C. 
kalbii and its constituents have revealed antinociceptive 
effects (Pereira, 1996; Maia et al., 2002), antimicrobial 
action against Staphylococcus aureus and Bacillus subtilis 
(Falcão et al., 2004; Ribeiro et al., 2002), and photoprotec-
tion capacity (Fernandez et al., 1998) as well as antioxi-
dant activity (Hidalgo et al., 1994). Additionally, a recent 
report has demonstrated the antinociceptive property of 
ATR in mice (Melo, 2008; Siqueira et al., 2010). Despite 
the widespread medicinal use of C. kalbii root extracts in 
Brazil and elsewhere, there are no published studies on 
their toxicological and anti-inflammatory properties.
This study aimed to evaluate the anti-inflammatory 
activity, cytotoxicity, and toxic effects of acute (single 
dose) and subchronic (30 days) oral administration of ATR 
extracted from C. kalbii in rodents. 
MATERIAL AND METHODS
Lichen material
C. kalbii was collected in March 2007 in Itabaiana, 
State of Sergipe, Northeastern Brazil (10º44’S, 37º23’W), 
and identified by M.P. Marcelli (Botanical Institute of São 
Paulo-SP, Brazil). SP 393235.
Extraction and isolation of ATR
ATR (C19H18O8) was isolated from the crude extract 
of the lichen C. kalbii. The air-dried parts (100 g) of C. 
kalbii were extracted with 150 mL of chloroform using a 
Soxhlet apparatus to isolate ATR. The crude extract was 
filtered and stored at 4 °C for 24 h for ATR precipitation.
Animals
Male and female Wistar rats (150-200 g) and male 
Swiss mice (28-32 g) were obtained from Universidade 
Federal de Sergipe, Brazil. Toxicity tests were performed 
in male and female rats and anti-inflammatory tests were 
performed only in male rats or mice. The animals were 
kept under standard laboratory conditions (20±2 ºC) and 
housed in polypropylene cages, with food and water ad 
libitum. All experimental protocols were approved by the 
Institutional Animal Care and Use Committee of Univer-
sidade Federal de Sergipe (CEPA/UFS 100/2006). All 
experiments were performed from 1:00 p.m. to 6:00 p.m.
Anti-inflammatory study
Carrageenan-induced hind paw edema in rats
Acute hind paw edema was induced in male rats by 
injecting 0.1 mL of carrageenan (prepared as 1% suspen-
sion in sterile normal saline) into the subplantar region of 
the right hind paw (Winter et al., 1962). ATR (50, 100, and 
200 mg/kg, p.o.) was administered to three different groups, 
while two other groups served as negative and positive 
controls and received vehicle (0.9% saline with two drops 
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FIGURE 1 - Chemical structure of atranorin.
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of 0.2% Tween 80, a solvent for ATR) and standard drug 
(aspirin, 300 mg/kg, p.o.), respectively. ATR and aspirin 
were administered 1 h prior to the injection of carrageenan. 
The rat pedal volume up to the ankle joint was measured us-
ing a plethysmometer (Model LE 7500 Panlab, Barcelona, 
Spain) at 3 h after the injection of carrageenan.
Leukocyte migration to the peritoneal cavity
Leukocyte migration was induced by injection of 
500 µL of carrageenan (500 µg/cavity, i.p.) into the peri-
toneal cavity of male mice 1 h after administration of ATR 
(50, 100, and 200 mg/kg, p.o.), vehicle (0.9% saline with 
two drops of 0.2% Tween 80), or dexamethasone (2 mg/kg, 
s.c., n = 6) by a modification of the technique previously 
described by Bastos et al. (2007). Mice were euthanized by 
cervical dislocation 4 h after carrageenan injection. Shortly 
after, phosphate-buffered saline (PBS) containing EDTA 
(1 mM, i.p., 10 mL) was injected. Immediately after, the 
abdomen was briefly massaged for further fluid collec-
tion, which was centrifuged (2000 rpm, 5 min) at room 
temperature. The supernatant was disposed and 1 mL of 
PBS was added to the precipitate. A 10-µL aliquot of this 
suspension was diluted in 200 µL of Turk solution, and 
total cells were counted in a Neubauer chamber under opti-
cal microscopy. The results were expressed as the number 
of leukocytes/mL. The percentage of leukocyte inhibition 
(%LI) was calculated as follows: %LI = (1 – T/C) x 100, 
where T represents the test groups’ leukocyte counts, and 
C represents the control groups’ leukocyte counts.
Toxicological studies
Subchronic toxicity study
Toxicological assays were performed with 20 male 
and 20 female rats, divided into 4 groups of 10 animals 
each (experimental and control groups of male and female 
rats) (BRASIL, 2004). For the subchronic study, daily 
doses of ATR (50 mg/kg) dissolved in saline with 0.2% 
Tween 80 (vehicle) were administered to the experimental 
groups over a 30-day period, whereas the controls received 
only saline. 
At the end of the experimental period, and after a 
12 h fast, the animals were anesthetized with thiopental 
(50 mg/kg) and blood (3-5 mL) was collected from the 
abdominal aorta. Subsequently, the animals were sac-
rificed (hemorrhagic shock) and a detailed study of the 
gross and microscopic features of internal organs as well 
as hematological and biochemical analyses of blood were 
carried out. The position, shape, size, texture, consistency, 
and color of internal organs (lungs, heart, liver, viscera, 
and kidneys) were macroscopically examined for any 
signs of gross changes. These organs were then collected, 
weighed to determine relative organ weights, and fixed in 
10% phosphate-buffered formalin solution for subsequent 
histological procedures.
Acute toxicity study
Toxicological assays were performed with 12 male 
and 12 female rats, divided into 4 groups of 6 animals each 
(experimental and control groups of male and female rats) 
(BRASIL, 2004). The animals received 5 g/kg of ATR by 
oral administration (gavage). ATR, dissolved in saline with 
0.2% Tween 80 (vehicle), was administered to the experi-
mental groups, whereas the controls received only saline.
Specific behaviors (sedation, reduced ambulation, 
response to touch, analgesia, and defecation) were ob-
served and graded according to Almeida et al. (1999) at 1, 
2, 3, and 4 h after gavage. Finally, the animals were moni-
tored daily for 14 days to verify lethality. At the end of 
the experimental period, and after a 12 h fast, the animals 
were anesthetized with thiopental and blood was collected 
from the abdominal aorta. Subsequently, the animals were 
sacrificed (hemorrhagic shock) and a detailed study of the 
gross and microscopic features of internal organs as well 
as hematological and biochemical analyses of blood were 
carried out. The position, shape, size, texture, consistency, 
and color of internal organs (lungs, heart, liver, viscera, 
brain, and kidneys) were macroscopically examined for 
any signs of gross changes. These organs were then col-
lected, weighed to determine relative organ weights, and 
fixed in 10% phosphate-buffered formalin solution for 
subsequent histological procedures.
Parameters
Hematological analysis
Blood samples were collected into EDTA tubes. 
Measurements of erythrocytes, hemoglobin, hematocrit, 
leukocyte, neutrophil, lymphocyte, eosinophil, mono-
cyte, basophil, atypical lymphocyte, and platelets were 
determined using Pentra-120 (ABX-HORIBA) automated 
equipment according to the method described by Morris 
and Davey (1999).
Biochemical parameters
Serum was separated from non-heparinized blood 
and assayed for serum urea, creatinine, total protein, 
globulin, albumin, aspartate aminotransferase (AST), ala-
nine aminotransferase (ALT), gamma-glutamyl transferase 
(GGT), total bilirubin (TBIL), direct bilirubin (DBIL), al-
kaline phosphatase (ALP), lactate dehydrogenase (LDH), 
calcium, sodium, potassium, and uric acid. Biochemical 
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parameters were determined using Dade Behring Dimen-
sion RxL automated equipment.
Tissue analysis
Formalin-fixed samples of internal organs were de-
hydrated, cleared, and embedded in paraffin according to 
standard histological procedures. Then, 5 µ-thick sections 
of paraffin-embedded tissues were obtained and stained 
with hematoxylin-eosin. Morphological analysis of the 
histological sections was performed by light microscopy 
in a blinded fashion, following a numerical protocol so that 
the pathologist was blinded to treatment groups until the 
end of the experiment. Morphometric analysis was used 
to compare mean kidney glomerular perimeter between 
female rats (control and test groups). The images were 
digitized using 5 histological fields for each case (200x 
magnification), employing an Olympus image capture 
system. The digital images were then processed using 
specific morphometry software (Image Tool 3.0). 
Determination of cytotoxicity
L929 cells (fibroblast cells) from the Rio de Janeiro 
Cell Bank, University of Rio de Janeiro, Rio de Janeiro, 
Brazil, were routinely grown in 150 cm2 tissue culture flasks 
in DMEM supplemented with 1% (v/v) of an antibiotic so-
lution containing 5 mg of penicillin, 5 mg of streptomycin 
and 10 mg of neomycin per mL, and 7.5% or 10.0% (v/v) 
heat-inactivated fetal bovine serum at 37ºC under 5% CO2.
MTT assay
Cell sensitivity to ATR was determined by standard 
spectrophotometric 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. Cells were 
seeded at a density of 105 cells/well into 96-well plates 
and incubated for 24 h at 37ºC in a 95% air, 5% CO2 atmo-
sphere. Then, 20 µL of ATR at different concentrations in 
PBS was added to the culture plates for 24 h. After treat-
ment, cells were rinsed once with PBS. Serum-free culture 
medium, without phenol red, was added back to all wells. 
Cells were then incubated for 4 h with MTT solution (5 
mg/mL). The yellow tetrazolium salt was metabolized by 
viable cells to form purple formazan crystals. The crystals 
were solubilized overnight (12 h) in a mixture consisting 
of 20% sodium dodecyl sulfate (SDS) in HCl (0.01 M). 
The product was quantified spectrophotometrically by 
measuring absorbance at 570 nm using a microplate reader 
(µQuantTM, BioTek Instruments Inc., USA). Cell viability 
was expressed as the percentage of viable cells in relation 
to the control cells.
Statistical analysis
The Student t test was employed in the statistical 
analysis of the results (Origin 6.2 or GraphPad Prism 
4.01). Data obtained from the anti-inflammatory study 
were evaluated by one-way analysis of variance (ANO-
VA), followed by Dunnett’s or Fisher’s tests. All values 
were expressed as back-transformed mean ± standard de-
viation (SD). Differences between groups were considered 
statistically significant at p < 0.05.
RESULTS AND DISCUSSION
Anti-inflammatory study
The mean increase in paw edema volume was about 
0.82±0.17 mL in vehicle-treated rats. ATR (100 and 
200 mg/kg, p.o.) significantly reduced (p < 0.05) mean 
paw edema volume (29.3 and 32.9%, respectively), as 
compared with the control group, at 3 h after carrageenan 
injection. Similarly, aspirin (300 mg/kg, p.o.) showed 
highly significant (p < 0.001) anti-inflammatory activity, 
with a 76.4% inhibition rate (Table I).
Several mediators are released by carrageenan 
in the rat paw. The initial phase of the response to car-
rageenan may be due to the release of histamine and 
serotonin, whereas kinins may play a role in the middle 
phase (Di Rosa, Sorrentino, 1968), and prostaglandins 
may be the most important mediators in the final 3-5 h 
of the post-carrageenan response (Vinegar et al., 1969). 
Bugni et al. (2009) showed that part of the antinocicep-
tive effect obtained with ATR may be due to inhibition of 
cyclooxygenase (COX) enzymes. Additionally, Siqueira 
et al. (2010) suggested that ATR modulates neurogenic 
and inflammatory pain in capsaicin- and formalin-induced 
orofacial pain test models through a naloxone-sensitive 
mechanism. 
Figure 2 shows the inhibitory effect of ATR on 
carrageenan-induced leukocyte migration into the perito-
neal cavity 4 h after stimulus at all doses (31.9, 35.9, and 
42.5% at doses of 50, 100, and 200 mg/kg, respectively; 
p < 0.05). The results obtained with the control group 
support the effect of ATR, since the vehicle showed no 
activity and the control drug (dexamethasone, 2 mg/kg, 
s.c.) inhibited leukocyte migration (92.2%, p < 0.001), as 
compared with the control group.
Cell recruitment during inflammation depends on 
the orchestrated release of local mediators responsible for 
local vascular and tissue changes as well as for the recruit-
ment of host defense cells (Luster et al., 2005). Inflam-
mation induced by carrageenan involves cell migration, 
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TABLE I - Effect of atranorin (ATR) or aspirin on carrageenan-induced hind paw edema in rats (n = 8)
Treatment Dose (mg/kg) Carrageenan-induced hind paw 
edema volume (mL)a
% inhibition
Vehicle - 0.82 ± 0.17 -
ATR 50 0.77 ± 0.15 6.1
ATR 100 0.58 ± 0.11b 29.3d
ATR 200 0.55 ± 0.08b 32.9d
Aspirin 300 0.21 ± 0.05c 76.4e
a Values expressed as mean ± standard error of the mean (SEM).
b P < 0.05 (one-way ANOVA and Dunnett’s test), significantly different from control.
c P < 0.001 (one-way ANOVA and Dunnett’s test), significantly different from control.
d P < 0.05 (Fisher’s test), significantly different from control.
e P < 0.001 (Fisher’s test), significantly different from control.
FIGURE 2 - Effect of atranorin (ATR) on carrageenan-induced 
leukocyte migration into the peritoneal cavity in mice. Groups of 
mice were pretreated with vehicle (control group, 10 mL/kg, p.o.), 
dexamethasone (Dexa, 2 mg/kg, s.c.), or ATR at concentrations 
of 50, 100, and 200 mg/kg (p.o.) 60 min before carrageenan 
(500 µg/cavity, 500 µL, i.p.)-induced peritonitis. Cell counts 
were performed at 4 h after injection of carrageenan. Values 
are expressed as mean ± standard error of the mean (SEM). 
*p < 0.05 and **p < 0.001 when compared to control group. 
ANOVA followed by Dunnett’s test (n = 6, per group).
plasma exudation, and production of chemical mediators, 
such as nitric oxide, prostaglandin E2, interleukin (IL)-1β, 
IL-6, and tumor necrosis factor (TNF)-α (Salvemini et al., 
1996; Loram et al., 2007). Those mediators are able to 
recruit leukocytes, such as neutrophils, as demonstrated 
in several experimental models.
Kumar and Muller (1999) demonstrated that ATR 
effectively inhibits the biosynthesis of leukotriene B4 in 
bovine polymorphonuclear leukocytes, which could also 
lead to an anti-inflammatory effect. Because ATR inhibited 
carrageenan-induced paw edema volume and leukocyte 
migration, it may be suggested that these activities are 
related to inhibition of the synthesis of many inflamma-
tory mediators, whose involvement in cell migration is 
well established.
Subchronic toxicity study
Administration of ATR (50 mg/kg, p.o.) for 30 days 
did not modify the profile of weight gain when test and 
control groups were compared (Figure 3). In addition, food 
and water consumption for control and treated animals was 
kept within the established limits for this animal species.
There were no changes in the weight of lungs, heart, 
liver, and stomach (Table II) 30 days after subchronic 
treatment with 50-mg/kg ATR. The internal organs of 
both control and treated animals showed no unusual signs. 
FIGURE 3 - Changes in rat body weight during 30-day atranorin 
(ATR) treatment (50 mg/kg). Each point represents mean ± 
standard deviation (SD) of n = 10.
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Moreover, both macro and microscopic analyses revealed 
normal findings. The organs of both control and treated 
groups were unremarkable and comparable to each sex. 
There was no further evidence of histopathological chang-
es. The architecture and cell appearance of the examined 
internal organs were comparatively unremarkable in both 
groups and sexes. Only the female rats showed significant 
differences in the relative weight of the kidneys, as shown 
in Table II.
Thus, a morphometric analysis was performed in 
the kidney glomerular cells, which showed no significant 
differences when compared to test and control groups. Sci-
entific literature on the renal histology and morphometry 
of animals treated with lichens is still rare. The differences 
in kidney weights could suggest a renal reduction in the 
area of glomerular corpuscle and capsular space (Daniels, 
Hostetter, 1990). However, gross and microscopic patho-
logic examination of the kidneys detected no abnormali-
ties. Also, the values observed for kidney weight are con-
sistent with the limits considered normal for this animal 
species, according to Hossne et al. (1986).
Results of the hematological study are presented 
in Table III. The data show that hemoglobin, hematocrit, 
leukocyte, neutrophil, lymphocyte, eosinophil, mono-
cyte, basophil, atypical lymphocyte, and platelet levels 
for the control rats were not significantly different from 
TABLE II - Changes in organ weight of rats after subchronic oral treatment with atranorin (ATR) at a daily dose of 50 mg/kg for 
30 days
Organ weight
Groups Lung (g) Heart (g) Liver (g) Kidneys (g) Stomach (g)
CF 1.52 ± 0.21 0.81 ± 0.09 7.45 ± 0.85 1.91 ± 0.28 3.85 ± 0.99
TF 1.45 ± 0.13 0.77 ± 0.08 7.43 ± 0.50 1.54 ± 0.09* 3.95 ± 0.70
CM 2.39 ± 0.26 1.45 ± 0.20 9.97 ± 2.03 3.01 ± 0.31 8.84 ± 1.25
TM 2.54 ± 0.31 1.47 ± 0.20 9.98 ± 1.11 2.88 ± 0.22 9.36 ± 1.60
CF = control female; CM = control male; TF = treated female; TM = treated male.
Data are expressed as mean ± standard deviation (SD), n = 10.
* Indicates statistical difference between control and ATR groups (p < 0.05).
TABLE III - Effect of 30-day oral administration of atranorin (ATR) on hematological parameters, considering sex interaction, in 
Wistar rats (n = 10)
Groups
Parameters CF TF UFS Female 
Vivarium 
CM TM UFS Male 
Vivarium
Erythrocytes (×106/mm3) 8.32 ± 0.17 8.14 ± 0.40 7.3 - 8.64 8.28 ± 0.58 7.74 ± 0.42* 6.7 – 8.6
Hemoglobin (g/dl) 14.10 ± 0.33 13.83 ± 0.52 13.2 - 15.1 15.94 ± 0.77 15.33 ± 0.56 12.8 - 15.9
Hematocrit (%) 42.93 ± 0.94 41.76 ± 1.86 39.1 - 48.5 45.55 ± 3.48 42.57 ± 3.15 39.1 - 48.7
Leukocyte (×103/mm3) 6.41 ± 1.00 7.07 ± 0.97 4.7 - 12.98 7.72 ± 1.43 7.25 ± 1.83 5.7 - 13.9
Neutrophil (%) 4.12 ± 1.24 4.11 ± 0.33 5.4 - 37.5 20.40 ± 6.83 18.33 ± 4.21 17.1 - 47.9
Lymphocyte (%) 94 ± 1.77 94.11 ± 0.60 57.9 - 90.0 65.90 ± 7.04 68.55 ± 3.20 48.7 - 78.1
Eosinophil (%) 0 0 0.2 - 4.5 0 0 0.3 - 4.0
Monocyte (%) 1.25 ± 0.46 1 0.6 – 7.9 13.7 ± 2.40 13.11 ± 1.69 1.0 - 6.5
Basophil (%) 0.5 ± 0.53 0.66 ± 0.50 0 - 0.8 0 0 0 - 0.8
Atypical lymphocyte (%) 0.12 ± 0.35 0.11 ± 0.33 0 -1.0 0 0 0 -1.0
Platelets (×103/mm3) 9627.5 ± 58.21 9940.00 ± 72.83 757 - 1476 7352 ± 20.13 7352 ± 25.84 837 - 1455
CF = control female; CM = control male; TF = treated female; TM = treated male; UFS = Universidade Federal de Sergipe, 
Northeastern Brazil.
Data are expressed as mean ± standard deviation (SD), n = 10.
* Indicates statistical difference between control and ATR groups (p < 0.05).
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those of ATR-treated rats during the study period (Table 
III). Only erythrocyte counts were significantly lower in 
treated males 30 days after treatment, as compared to the 
control group (p < 0.05). However, these values could be 
considered normal because, according to Schalm (1986), 
the number of erythrocytes may range from 5.25 to 8.5 
million in male rats. Furthermore, these values are also 
in agreement with the reference values for rats in the uni-
versity vivarium (these reference values were determined 
in a recent survey, but such data are not yet published).
The increase in erythrocytes may be due to over-
production of hematopoietic regulatory elements, such 
as colony-stimulating factors, erythropoietin, and throm-
bopoietin, by stromal cells and macrophages in the bone 
marrow (Chang-Gue et al., 2003), thus providing a local 
environment for hematopoiesis (Udut et al., 2005). In ad-
dition, the fact that such a significant difference was not 
verified between the female groups supports the idea that 
this finding is merely contingent. 
Plasma biochemical data are described in Table IV. 
No significant changes were observed in urea, creatinine, 
albumin, AST, ALT, LDH, calcium, sodium, potassium, 
and uric acid. Nevertheless, the study showed an in-
crease in total protein and globulin, demonstrating that 
liver function was preserved (Motta, 2003). Furthermore, 
the increase in GGT, DBIL, and ALP revealed biliary 
cholestasis (Henry, 2008), probably due to an incipient 
inflammatory process.
The histopathological examination of selected 
organs (lungs, heart, liver, viscera, and kidneys) from 
treated and control animals showed normal architecture, 
suggesting that daily oral administration of ATR for 30 
days caused no detrimental changes or morphological 
disturbances.
Acute toxicity study
In the acute toxicity test, doses of 5 g/kg of ATR 
TABLE IV - Serum biochemical findings in rats treated with atranorin (ATR) at a daily dose of 50 mg/kg for 30 days
Groups
Parameters CF TF UFS Female 
Vivarium
CM TM UFS Male 
Vivarium
Urea (mg/dL) 58.80 ± 33.40 43.70 ± 5.91 30 – 57 37.30 ± 4.16 33.70 ± 4.08 30 - 42
Creatinine (mg/dL) 0.40 ± 0.22 0.41 ± 0.09 0.4 – 0.7 0.40 ± 0.04 0.33 ± 0.11 0.44 – 0.64
Total protein (g/dL) 6.10 ± 0.40 6.43 ± 0.27* 6.1 - 7.4 5.38 ± 0.32 5.47 ± 0.22 5.4 – 6.6
Globulin (g/dL) 4.71 ± 0.39 5.12 ± 0.21* 3.1 - 4.3 4.36 ± 0.24 4.44 ± 0.16 2.7 - 3.5
Albumin (g/dL) 1.32 ± 0.05 1.31 ± 0.07 2.6 - 3.4 1.02 ± 0.10 1.03 ± 0.09 2.7 - 3.2
AST (U/L) 77.33 ± 11.21 68.33 ± 6.74 83 - 184 122.22 ± 45.46 100.74 ± 18.63 81 – 180
ALT (U/L) 63.75 ± 17.46 74.36 ± 7.07 26 – 60 70.87 ± 23.7 60.88 ± 9.31 36 – 58
GGT (U/L) 8.79 ± 1.39 12.11 ± 1.26* -- 8.91 ± 1.37 8.82 ± 0.91 __
TBil (mg/dL) 0.07 ± 0.02 0.12 ± 0.02* 0.07 – 0.09 0.25 ± 0.05 0.24 ± 0.03 0.07 – 0.08
DBil (mg/dL) 0.02 ± 0.01 0.05 ± 0.01* 0.01 – 0.03 0.17 ± 0.01 0.16 ± 0.01 0.01 – 0.03
IBil (mg/dL) 0.04 ± 0.02 0.06 ± 0.01* 0.01 – 0.01 0.5 ± 0.28 0.39 ± 0.28 0.01 – 0.01
ALP (U/L) 100.8 ± 46.84 156.8 ± 36.52* 63 - 138 89.27 ± 28.0 73.49 ± 7.04 79 - 196
LDH 305.1 ± 89.71 219 ± 116.29 -- 1270.5 ± 14.84 979.00 ± 318.4 --
Ca2+ (mEq/L) 9.83 ± 0.48 10.08 ± 0.48 10.42 ± 0.28 10.53 ± 0.35 --
Na+ (mEq/L) 142.3 ± 10.78 145.55 ± 1.23 135 - 144 140.23 ± 1.31 140.00 ± 0.83 132 - 146
K+ (mEq/L) 4.46 ± 1.12 4.31 ± 0.76 4.2 – 6.4 5.79 ± 1.55 5.81 ± 0.58 3.7 – 5.7
Uric acid (mg/dL) 1.44 ± 0.57 1.41 ± 0.80 0.9 - 2.0 2.49 ± 1.26 2.02 ± 0.54 0.9 - 2.0
ALP = alkaline phosphatase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; CF = control female; CM = 
control male; DBil = direct bilirubin; GGT = gamma-glutamyl transferase; IBil = indirect bilirubin; LDH = lactate dehydrogenase; 
TBil = total bilirubin; TF = treated female; TM = treated male; UFS = Universidade Federal de Sergipe, Northeastern Brazil.
Data are expressed as mean ± standard deviation (SD), n = 10.
* Indicates statistical difference between control and ATR groups (p < 0.05).
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caused no deaths in rats during a 14-day observation 
period. The rats showed no signs of toxicity or changes 
in general behavior or any other physiological activities. 
Except for reduced locomotor activity (‘hypoactivity’) 
and lethargy, observed within the first 24 hours of ATR 
administration (at a single dose of 5 g/kg), no other signs 
of toxicity were noted in rats treated with oral ATR. Figure 
4 shows a graphical representation of changes in body 
weight following the treatment of rats with ATR and saline. 
There was a significant increase (p < 0.05) in body weight 
over the experimental period for all treatment groups. 
As shown in Table V, organ weights (lung, heart, 
liver, viscera, and brain) of ATR-treated rats did not differ 
from those of the control group.
Hematological analysis in the acute study (Table 
VI) showed no significant differences in the parameters 
examined in control or treated animals of both sexes. At a 
dose of 5 g/kg (single dose), only the male group showed a 
significant decrease in lymphocyte (%), as compared with 
the corresponding control group. In contrast, there was no 
significant change in any of the differential lymphocyte 
counts in female rats. Moreover, the difference noted in 
lymphocyte count between groups is within the reference 
values given by Mitruka and Rawnsley (1981), 65-84.5%, 
suggesting the absence of clinically relevant alterations.
The biochemical profile of treated and control rats is 
presented in Table VII. Acute oral administration of ATR 
(5 g/kg-single dose) only altered bilirubin levels, with no 
significant changes in serum urea, creatinine, globulin, 
AST, ALT, GGT, DHL, calcium, potassium, and uric acid. 
Because of a significant increase in TBIL and DBIL alone, 
it may be suggested that a reduction in conjugation rate oc-
curs within the hepatocyte (Henry, 2008). Altered ALP and 
sodium levels in the male group were considered normal, 
since they are in agreement with the reference values for 
rats in the university vivarium. In addition, no abnormali-
ties or further evidence of histopathological changes were 
found in any of control or treated rats of both sexes.
Gross pathologic examination of the tissues detected 
no abnormality in weight or appearance between control 
and experimental groups. Moreover, the organs of both 
groups were unremarkable and comparable to each sex. 
Microscopic analysis revealed that the architecture and 
cell appearance of the internal organs were comparatively 
unremarkable in both groups and sexes. These findings 
indicate that oral administration of purified ATR extracted 
from C. kalbii promotes no morphological changes in the 
vital organs of animals and suggest that this substance 
provides no toxicological effects.
Determination of cytotoxicity
MTT is a water-soluble tetrazolium salt, which is 
converted to an insoluble purple formazan product by 
cleavage of the tetrazolium ring by succinate dehydro-
genase activity within the mitochondria. The formazan 
product is impermeable to cell membranes and therefore 
accumulates in healthy cells (Fotakis, Timbrell, 2006).
ATR was evaluated in a mouse fibroblast cell line 
(L929) in order to examine its cytotoxic effects on normal 
FIGURE 4 - Changes in rat body weight during atranorin (ATR) 
treatment (5 g/kg-single dose). Each point represents mean ± 
standard deviation (SD) of n = 10.
TABLE V - Changes in organ weight of rats after acute oral treatment with atranorin (ATR) at a daily dose of 5 g/kg (single dose)
Groups Lung (g) Heart (g) Liver (g) Kidneys (g) Viscera (g) Brain (g)
CF 1.28 ± 0.02 0.61 ± 0.03 5.75 ± 0.33 1.35 ± 0.02 4.45 ± 0.07 1.30 ± 0.12
TF 1.15 ± 0.12 0.77 ± 0.11 5.76 ± 0.21 1.46 ± 0.16 3.20 ± 0.94 1.37 ± 0.11
CM 1.52 ± 0.31 0.98 ± 0.07 7.95 ± 0.51 1.59 ± 0.01 4.66 ± 1.23 1.2 ± 0.43
TM 1. 39 ± 0.02 0.96 ± 0.13 7.36 ± 1.63 2.01 ± 0.27 5.36 ± 3.85 1.66 ± 0.08
CF = control female; CM = control male; TF = treated female; TM = treated male.
Data are expressed as mean ± standard deviation (SD), n = 6. 
Anti-inflammatory and toxicity studies of atranorin extracted from Cladina kalbii Ahti in rodents 869
TABLE VI - Effect of oral administration of atranorin (ATR) (5 g/kg-single dose) on hematological parameters, considering sex 
interaction, in Wistar rats (n = 10)
Groups
Parameters CF TF UFS Female 
Vivarium
CM CT UFS Male 
Vivarium
Erythrocytes (×106/mm3) 7.12 ± 0.17 7.84 ± 0.54 7.3 - 8.64 8.28 ± 0.58 8.80 ± 0.39 6.7 – 8.6
Hemoglobin (g/dl) 15.3 ± 0.21 14.7 ± 0.37 13.2 - 15.1 15.94 ± 0.77 15.8 ± 0.61 12.8 - 15.9
Hematocrit (%) 40.65 ± 0.91 41.96 ± 1.26 39.1 - 48.5 45.55 ± 3.48 44.45 ± 1.37 39.1 - 48.7
Leukocyte (×103/mm3) 7.10 ± 0.14 8.13 ± 0.30 4.7 - 12.98 7.72 ± 1.438 9.70 ± 1.43 5.7 - 13.9
Neutrophil (%) 12.5 ± 0.63 9.00 ± 1.14 5.4 - 37.5 20.4 ± 6.83 14 ± 5.65 17.1 - 47.9
Lymphocyte (%) 85.5 ± 4.94 88.66 ± 1.15 57.9 - 90.0 65.9 ± 7.04 84.02 ± 8.61* 48.7 - 78.1
Eosinophil (%) 1 ± 0 1 ± 0 0.2 - 4.5 1 ± 0 1 ± 0 0.3 - 4.0
Monocyte (%) 1 ± 0 2 ± 0 0.6 – 7.9 13.7 ± 2.40 12.75 ± 3.5 1.0 - 6.5
Basophil (%) - - 0 - 0.8 - - 0 - 0.8
Atypical lymphocyte (%) - - 0 -1.0 - - 0 -1.0
Platelets (×103/mm3) 741.00 ± 12.72 905.00 ± 11.52 757 - 1476 735.20 ± 20.21 845.50 ± 15.87 837 - 1455
CF = control female; CM = control male; TF = treated female; TM = treated male; UFS = Universidade Federal de Sergipe, 
Northeastern Brazil.
Data are expressed as mean ± standard deviation (SD), n = 6.
* Indicates statistical difference between control and ATR groups (p < 0.05). 
TABLE VII - Serum biochemical findings in rats treated with atranorin (ATR) at a single dose (5 g/kg)
Groups
Parameters FC FT UFS Female 
Vivarium
MC MT UFS Male 
Vivarium
Urea (mg/dL) 50.00 ± 12.72 35.66 ± 4.50 30 - 57 37.3 ± 4.16 37.25 ± 2.62 30 – 42
Creatinine (mg/dL) 0.51 ± 0.14 0.5 ± 0.10 0.4 - 0.7 0.4 ± 0.04 0.37 ± 0.05 0.44 - 0.64
Total Protein (g/dL) 6.00 ± 0.28 4.62 ± 3.19 6.1 - 7.4 5.38 ± 0.32 5.8 ± 0.31* 5.4 - 6.6
Globulin (g/dL) 4.85 ± 0.21 4.56 ± 0.46 3.1 - 4.3 4.36 ± 0.24 4.5 ± 0.31 2.7 - 3.5
Albumin (g/dL) 1.15 ± 0,07 1.35 ± 0.12 2.6 - 3.4 1.02 ± 0.10 1.3 ± 0,00* 2.7 - 3.2
AST (U/L) 110.00 ± 0.56 95.66 ± 10.21 83 - 184 122.71 ± 45.46 120.50 ± 32.46 81 – 180
ALT (U/L) 63.01 ± 0,03 55.66 ± 11.93 26 - 60 70.80 ± 23.73 77.50 ± 21.62 36 – 58
GGT (U/L) 9.51 ± 0.70 8.01 ± 1.73 -- 8.90 ± 1.37 7.25 ± 1.70 __
TBil (mg/dL) 0.54 ± 0.03 0.56 ± 0.02 0.07 – 0.09 0.25 ± 0.05 0.46 ± 0.23* 0.07 – 0.08
DBil (mg/dL) 0.11±0 0.06 ± 0.04 0.01 – 0.03 0.17 ± 0.01 0.05 ± 0.02* 0.01 – 0.03
IBil (mg/dL) 0.43 ± 0.03 0.5 ± 0.02 0.01 – 0.01 0.51 ± 0.28 0.41 ± 0.20 0.01 – 0.01
ALP (U/L) 91 ± 9.89 95.66 ± 21.59 63 - 138 89.2 ± 28.09 153.25 ± 15.26* 79 – 196
LDH (U/L) 772.00 ± 244.65 841.33 ± 371.81 -- 1563.0 ± 188.0 1170.5 ± 225.5 --
Ca2+ (mEq/L) 9.75 ± 0.21 10.51 ± 0.41 -- 10.49 ± 0.28 10.52 ± 0.29 --
Na+ (mEq/L) 135.50 ± 0.70 136.66 ± 0.57 132 - 146 140.2 ± 1.31 136.5 ± 1.00* 132 - 146
K+ (mEq/L) 4,25±0,21 5,8±1,53 3.7 – 5.7 5,79±1,55 5.35 ± 1.19 3.7 – 5.7
Uric acid (mg/dL) 1.4 ± 0.28 1.54 ± 0.68 1.2 - 2.5 2.49 ± 1.26 1.30 ± 0.43 0.9 - 2.0
ALP = alkaline phosphatase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; CF = control female; CM = 
control male; DBil = direct bilirubin; GGT = gamma-glutamyl transferase; IBil = indirect bilirubin; LDH = lactate dehydrogenase; 
TBil = total bilirubin; TF = treated female; TM = treated male; UFS = Universidade Federal de Sergipe, Northeastern Brazil.
Data are expressed as mean ± standard deviation (SD), n= 6.
* Indicates statistical difference between control and ATR groups (p < 0.05).
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cells. ATR cytotoxicity on the growth of L929 cells is 
shown in Figure 5. Cell proliferation was analyzed 24 h 
after L929 cells had been cultured with ATR at 0.01, 0.02, 
0.04, 0.08, and 0.16 mg/mL using MTT assay. ATR at con-
centrations of 0.01-0.16 mg/mL did not show cytotoxic ef-
fects on the L929 cell line. These results suggest that ATR 
has no cytotoxic effects at these concentrations. Melo et al. 
(2011) reported an effect of ATR on SH-SY5Y cultures, a 
neuroblastoma-derived catecholaminergic cell line.
Different concentrations of ATR alone had no effect 
on cell viability, as assessed by MTT assay. When cells 
are treated with H2O2, there is a significant decrease in cell 
viability to 40% of control levels. Co-incubation with ATR 
protects SH-SY5Y cells against the cytotoxic effects of 
H2O2. Nonetheless, all ATR concentrations reversed the 
effect of H2O2 (Melo et al., 2011).
CONCLUSION
In summary, data from the present study indicated 
that ATR has anti-inflammatory properties, but further 
studies are necessary to establish its correct mechanism 
of action. It is possible to speculate about the inhibition of 
the synthesis of many inflammatory mediators involved in 
cell migration. Additionally, there were no relevant signs 
or significant changes in hematological, biochemical, and 
histopathological parameters resulting from the long-term 
administration of ATR. It is therefore concluded that ATR, 
at the doses used in this study, produced no remarkable 
toxic effects on rats and might be an important tool in the 
management and/or treatment of inflammatory disorders.
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